3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
3
Lymphoma, Follicular
2
Plasmacytoma
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Microsatellite Stable Colorectal Carcinoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Hairy Cell
1
Colorectal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
durvalumab
1
cc-486
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Microsatellite Stable Colorectal Carcinoma
×
cc-486
×
Clear all
NCT02811497
2021-04-01
METADUR
University Health Network, Toronto
Phase 2
Completed
28 enrolled